【4503】アステラス製薬 : Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors

Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors

出所:株経通信(株式会社みんかぶ)
PDFをダウンロード